Full Text Journal Articles in
Journal Cardiovasc Revasc Med

Advertisement

Find full text journal articles






Assessment of 2-year mortality with use of drug-coated devices in femoropopliteal disease: A real world experience from the Bronx, New York.

Safiriyu Israel, Divya Gumber, Leonidas Palaiodimos, Seth Sokol, Sheetal V Mathai, Amit Shah, Aksim Rivera, Dimitris Karamanis, Amit Kakkar,

The use of drug-coated devices (DCD) in peripheral arterial disease (PAD) intervention continues to remain controversial after a recent meta-analysis raised concerns of higher late mortality outcome with the use of these devices. Given this, there is need for more data with regards to the late mortality outcome with DCD ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



3D transesophageal echocardiography for guiding transcatheter aortic valve replacement without prior cardiac computed tomography in patients with renal dysfunction.

David Hana, Tyler Miller, Paulina Skaff, Karthik Seetharam, Samian Suleiman, Bryan Raybuck, Akram Kawsara, Lawrence Wei, Harold Roberts, Christopher Cook, Vinay Badhwar, Ramesh Daggubati, James Mills, Partho Sengupta, Yasmin Hamirani,

<h4>Background</h4>Pre-procedural chronic kidney disease (CKD) and in-hospital acute kidney injury (AKI) are associated with worse outcomes following transcatheter aortic valve replacement (TAVR). We tested the feasibility of reducing overall AKI by avoiding pre-procedural cardiac CT angiography (CCTA) by using direct 3D-TEE guidance in TAVR patients with known CKD.<h4>Methods</h4>An institutional TAVR ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Bail-out intravascular lithotripsy for the treatment of acutely underexpanded stents in heavily calcified coronary lesions: A case series.

Mohamed A A Mousa, Brian O Bingen, Ibtihal Al Amri, Simonluca Digiacomo, Ioannis Karalis, J Wouter Jukema, Jose M Montero-Cabezas,

Stent underexpansion is a common problem in heavily calcified coronary lesions treated with percutaneous coronary intervention, and has been associated with in-stent restenosis, stent thrombosis and, subsequently, poor clinical outcomes. Adequate preparation of heavily calcified coronary lesions (e.g. using non-compliant balloons, cutting/scoring balloons, rotational/orbital atherectomy or intravascular lithotripsy) prior to ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Effect of genotype guided oral P2Y12 inhibitor selection after percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials.

Aaqib H Malik, Rahul Gupta, Sandipan Chakraborty, Pranav Mahajan, Dhrubajyoti Bandyopadhyay, Srikanth Yandrapalli, Syed Zaid, Jayakumar Sreenivasan, Abhishek Chaturvedi, Sanjay S Mehta, Apurva V Vyas, Nainesh C Patel, William G Combs, Hasan Ahmad,

<h4>Background</h4>Clopidogrel is the most frequently used P2Y12 inhibitor as a component of the dual antiplatelet regimen in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Prior studies have shown the variable efficacy of clopidogrel due to genotypic differences in the CYP2C19 enzyme function, which converts clopidogrel to ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Individualizing dual antiplatelet therapy (DAPT) duration based on bleeding risk, ischemic risk, or both: An analysis from the DAPT Study.

Nino Mihatov, Eric A Secemsky, Dean J Kereiakes, P Gabriel Steg, Donald E Cutlip, Ajay J Kirtane, Roxana Mehran, Bokai Zhao, Yang Song, C Michael Gibson, Robert W Yeh,

<h4>Background</h4>Guidelines recommend individualization of dual antiplatelet therapy (DAPT) duration. Whether to guide decisions based on bleeding risk, ischemic risk or a combination is not known.<h4>Aims</h4>To compare a bleeding prediction model, an ischemic prediction model, and the DAPT score in guiding DAPT duration.<h4>Methods</h4>11,648 patients in the DAPT Study were categorized into ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



The use of coronary sinus reducer for refractory angina in the U.S.: A case series.

Ryan Gindi, Sarah Gorgis, Mohamad Raad, William O'Neill, Gerald Koenig,

Chronic refractory angina remains a common and debilitating condition for millions of people, with up to 30% of patients experiencing persistent angina despite successful revascularization. We share our experience with the implantation of a coronary sinus reducer in two complex CAD patients with refractory angina despite multiple revascularization strategies and ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Successful transcatheter aortic valve in JenaValve in homograft implantation in a 33-year-old heart failure patient after aortic and mitral valve replacement due to severe endocarditis 18 years ago.

Selma Mietz, Mahmoud Diab, Laura Bäz, P Christian Schulze, Sven Möbius-Winkler, Marcus Franz,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Women making waves Editorial: Impact of sex in the functional assessment of intermediate coronary lesions by instantaneous wave-free ratio.

Mirvat Alasnag, Stephane Manzo-Silberman,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Five year clinical outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System.

Donald E Cutlip, Rajiv Jauhar, Perwaiz Meraj, Kirk N Garratt, Victor Novack, Lena Novack, Luc Maillard, Andrejs Erglis, Robert Stoler, Mark Barakat, Sigmund Silber, ,

<h4>Background/purpose</h4>The COBRA Polyzene F™ NanoCoated Coronary Stent System (PzF coated stent) stent demonstrated favorable clinical outcomes at 9 months but late results have not been reported. We sought to assess the late safety and effectiveness of the PzF coated stent for treatment of de novo coronary artery lesions.<h4>Methods</h4>Patients with de novo ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Extreme angiographic-physiologic mismatch with elevated left ventricular end-diastolic pressure.

Travis J Cohoon, Morton J Kern,

Translesional coronary pressure measures the hemodynamic significance of epicardial coronary artery disease. Angiographic-physiologic mismatching is attributed mainly to imaging limitations. We present a patient with extreme visual-physiologic functional mismatch and a markedly elevated left ventricular end diastolic pressure (LVEDP) as a potential contributory mechanism. ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Reaching for the ultimate radiation safety goal of zero.

Jeff Chambers, Matthew Whitbeck,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Incidence and characteristics of incomplete stent apposition in calcified lesions: An optical coherence tomography study.

Atsushi Kyodo, Hiroyuki Okura, Akihiko Okamura, Saki Iwai, Daisuke Kamon, Yukihiro Hashimoto, Tomoya Ueda, Tsunenari Soeda, Makoto Watanabe, Yoshihiko Saito,

<h4>Background</h4>Persistent or late acquired incomplete stent apposition (ISA) may be associated with late or very late stent thrombosis following drug-eluting stent implantation. Presence of calcium at the target lesion may increase the risk of ISA even after rotational atherectomy (RA) followed by stenting with high pressure balloon inflation. The aim ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Access route and clinical outcomes after ticagrelor versus prasugrel in patients with acute coronary syndrome undergoing invasive treatment strategy.

Rayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, Christian Valina, Maurizio Menichelli, Mohammad Abdelghani, Jochen Wöhrle, Ralph Toelg, Bernhard Witzenbichler, Nader Mankerious, Christoph Liebetrau, Isabell Bernlochner, Christian W Hamm, Abdelhakim Allali, Michael Joner, Massimiliano Fusaro, Erion Xhepa, Alexander Hapfelmeier, Sebastian Kufner, Hendrik B Sager, Stefanie Schüpke, Karl-Ludwig Laugwitz, Heribert Schunkert, Franz-Josef Neumann, Adnan Kastrati, Salvatore Cassese,

<h4>Background</h4>Whether the access site influences the comparative efficacy and safety of ticagrelor and prasugrel in patients with acute coronary syndrome (ACS) undergoing invasive treatment strategy remains unstudied.<h4>Methods</h4>This post-hoc analysis included ACS patients undergoing invasive treatment via radial or femoral access and randomized to either ticagrelor or prasugrel in the ISAR-REACT ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2022, :]

Cited: 0 times

View full text PDF listing >>



Impact of late lumen loss on clinical outcomes of side branch bifurcation lesions treated by drug-coated balloon angioplasty with main branch stenting.

Akihiro Ikuta, Shunsuke Kubo, Masanobu Ohya, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Kazushige Kadota,

<h4>Background</h4>Drug-coated balloon (DCB) angioplasty for side branches with main branch stenting is effective for bifurcation lesions and reduces late lumen loss (LLL) in side branches. However, the predictors and clinical implications of LLL after DCB angioplasty are largely unexplored.<h4>Methods</h4>Among 181 patients undergoing DCB angioplasty for side branches with drug-eluting stent ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Early discharge after transcatheter aortic valve implantation: Then what?

Romain Didier, Martine Gilard,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



One year outcomes for patients undergoing transcatheter aortic valve replacement: The Gulf TAVR registry.

Mirvat Alasnag, Khaled AlMerri, Abdulrahman Almoghairi, Abdullah Alenezi, Fawaz Bardooli, Shereen Al-Sheikh, Nouf Alanazi, Waleed AlHarbi, Hatim Al Lawati, Khalid Al Faraidy, Mohammed AlShehri, Michael Thabane, Lehana Thabane, Khaled Al-Shaibi,

<h4>Background</h4>The use of transcatheter aortic valve replacement (TAVR) is steadily increasing with TAVR procedures offered to patients across the entire spectrum of surgical risks. The Gulf TAVR registry captures the demographics of patients undergoing TAVR in the Gulf region, comorbidities that drive outcomes, procedural success, complications, and one-year outcomes of ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Transcatheter pulmonary valve implantation in carcinoid heart disease.

Michele Flagiello, Matteo Pozzi, Laurent Francois, Ahmed Al Harthy, Julien Forestier, Sara Boccalini, Gilles Rioufol, Thomas Walter, Jean Francois Obadia,

Carcinoid heart disease is a rare condition affecting mostly tricuspid and pulmonary valves causing right-sided heart failure. Surgical valve replacement is the mainstay of treatment when patients become symptomatic and/or in the presence of right heart remodeling. We present a case of severe pulmonary valve regurgitation secondary to carcinoid heart ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



An opportunity to improve secondary prevention with icosapent ethyl in patients who have undergone coronary artery bypass graft surgery.

Nick S R Lan, Umar S Ali, Robert Larbalestier, Girish Dwivedi, Damon A Bell,

<h4>Introduction</h4>Icosapent ethyl reduces cardiovascular events in high-risk patients with hypertriglyceridaemia on statin therapy. However, it is not widely available and the potential application following coronary artery bypass graft (CABG) surgery is not well-established. We aimed to determine the real-world percentage of CABG surgery patients who may be eligible for the ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Endpoints: Surrogates and composites.

Spencer B King,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Predicting transradial access (TRA) difficulty - we're getting better: Reliably reducing TRA failure to < 1 - 2% - a ways to go.

Jonathan Roberts,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Radial has come a long way; there is still a distance to go.

Ian C Gilchrist, Samer N Muallem, Jonathan M Norton,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The failing aspirations of aspiration thrombectomy in STEMI.

Huu Tam D Truong, Kwan S Lee,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The impact of the COVID-19 pandemic on the clinical status of patients referred for TAVR.

Joris F Ooms, Dilay Gunes, Thijmen W Hokken, Rik Adrichem, Rutger-Jan Nuis, Marjo De Ronde-Tillmans, Jeannette Goudzwaard, Francesco Mattace-Raso, Joost Daemen, Nicolas M Van Mieghem,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Sex differences in the clinical outcomes after left atrial appendage closure: A systematic review and meta-analysis.

Waiel Abusnina, Azka Latif, Ahmad Al-Abdouh, Mostafa R Mostafa, Qais Radaideh, Yazeid Alshebani, Ahmad Aboeata, Itsik Ben-Dor, Erin D Michos, Khagendra Dahal,

<h4>Introduction</h4>Left atrial appendage occlusion (LAAO) has emerged as a reasonable alternative to oral anticoagulation in a selective group of patients with atrial fibrillation (AF). While women are known have higher risk of AF-related stroke, the impact of sex differences on the clinical outcomes of LAAO has not been well studied.<h4>Objective</h4>We ... Read more >>

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The use of covered stents in coronary aneurysms: Effective and safe but still not FDA approved.

Nachiket J Patel, Richard R Heuser,

Cardiovasc Revasc Med (Cardiovascular revascularization medicine : including molecular interventions)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.8241 s